Compare Realty Income Corp (O) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Realty Income Corp vs GeneDx Holdings Corp — how do they compare? Realty Income Corp trades at $54.18 (market cap $51.26B), while GeneDx Holdings Corp trades at $67.33 (market cap $2.02B). The key difference: Realty Income Corp is far larger — about 25.4× GeneDx Holdings Corp's market cap, and Realty Income Corp pays a 6.01% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Realty Income Corp for 127 Days and GeneDx Holdings Corp for 19 Days on average.
| O | WGS | |
|---|---|---|
Market Cap | $51.26B | $2.02B |
Volume | 12,300,266 | 734,640 |
Sector | Real Estate | Health |
52-Week High | $67.56 | $167.51 |
52-Week Low | $53.35 | $34.51 |
Typical Hold Time | 127 Days | 19 Days |
Enterprise Value | $81.88B | $2.05B |
Dividend Yield | 6.01% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Realty Income (O) trades at $54.17, up 1.54% with a bearish technical signal despite recent dividend payments. The REIT shows strong fundamentals with 92.56% gross margins and 21.23% net income margin, though earnings have missed expectations for three consecutive quarters. Revenue growth continues from $5.3B in 2024 to $5.7B in 2025, while debt-to-asset ratio has increased to 39.93%.
Analysts maintain a cautious outlook with 38% buy ratings and $64.80 consensus target, representing 20% upside potential. Key risks include rising interest rates impacting REIT valuations and consecutive earnings misses. The stock offers income appeal with consistent dividends but faces headwinds from bond yield competition and technical weakness.
GeneDx (WGS) trades at $67.73, down 1.17% with bearish technical signals despite recent earnings beats. The company shows strong revenue growth to $454M in 2026 but faces profitability challenges with a -23.4% net margin. Recent developments include new genomic testing products and hospital partnerships, while analyst consensus remains strongly bullish with a $81 price target.
The stock presents a growth story with expanding genomic testing volumes but carries significant execution risk given negative profitability metrics. Upside potential exists if management can translate revenue growth into sustainable profits, though current cash flow trends and high valuation multiples warrant caution for risk-averse investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Realty Income Corp
Realty Income owns roughly 11,400 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in 49 states and Puerto Rico and are leased to 250 tenants from 47 industries. Recent acquisitions have added industrial, office, manufacturing, and distribution properties, which make up roughly 17% of revenue.
Read more on O →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
